Abstract:Transcription factor 7-like 2 (TCF7L2), which previously known as TCF-4, is a major form of transcription factor involved in the downstream WNT signaling and exhibits the strongest association to diabetes susceptibility. Although we still do not know mechanistically how TCF7L2 exerts its physiological functions on pancreatic endocrine cells, it had been suggested that TCF7L2 may directly affect β-cell function by regulating the activation of PI3K/AKT signaling pathway. MIN6 cells were transfected with TCF7L2 knockdown virus or lenti-TCF7L2 virus for 48 h to evaluate the contribution of TCF7L2 to the PI3K/AKT signaling pathway and pancreatic β-cell function. This was confirmed by measuring the expression of PI3K p85 and p-Akt by western blotting and insulin secretion by enzyme-linked immunosorbent assay (ELISA), respectively. Chromatin immunoprecipitation (ChIP) and polymerase chain reaction (PCR) experiments were performed to explore the genomic distribution of TCF7L2-binding sites in the promoter of PIK3R1, the affinity between which was analyzed by the luciferase reporter assay. In the present study, we strikingly identified that TCF7L2 could profoundly inhibit the expression of PIK3R1 gene and its encoding protein PI3K p85, which then could lead to the activation of PI3K/AKT signaling and stimulate insulin secretion in pancreatic β-cells. However, the integrity and stability of evolutionarily conserved TCF7L2-binding motif plays a very crucial role in the binding events between transcription factor TCF7L2 and its candidate target genes. We also found that the affinity of TCF7L2 to the promoter region of PIK3R1 alters upon the specific binding sites, which further provides statistical validation to the necessity of TCF7L2-binding motif. This study demonstrated that TCF7L2 is closely bound to the specific binding regions of PIK3R1 promoter and prominently controls the transcription of its encoding protein p85, which further affects the activation of PI3K/AKT signaling pathway and insulin secretion.

Insulin Upregulates the Expression of Zinc Finger and BTB Domain-Containing 7A in HepG2 Cells

Insulin Regulates the Expression of the Enhancer of Split- and Hairy-Related Protein-2 Gene Via Different Pathways in 3T3-L1 Adipocytes and L6 Myotubes

Stimulation of Endothelin-1 Gene Expression by Insulin Via Phosphoinositide-3 Kinase–glycogen Synthase Kinase-3Β Signaling in Endothelial Cells

SP1 Enhances Zbtb7A Gene Expression Via Direct Binding to GC Box in HePG2 Cells

Hepatic CREBZF Couples Insulin to Lipogenesis by Inhibiting Insig activity and Contributes to Hepatic Steatosis in Diet-Induced Insulin-Resistant Mice.

Global mapping of ZBTB7A transcription factor binding sites in HepG2 cells

B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells

Functional Expression of B7H1 on Pancreatic Carcinoma Panc-1 Cells

Insulin promotes hepatocarcinoma tumorigenesis by up-regulating PKM2 expression

BTB/POZ domain-containing protein 7: epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma.

ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma

Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1‐driven gluconeogenesis

The LIM-homeodomain Protein ISL1 Activates Insulin Gene Promoter Directly Through Synergy with BETA2.

Overexpression of B7-H1 correlates with malignant cell proliferation in pancreatic cancer.

Downregulation of AZGP1 by Ikaros and Histone Deacetylase Promotes Tumor Progression Through the PTEN/Akt and CD44s Pathways in Hepatocellular Carcinoma.

Insulin Induces C2c12 Cell Proliferation and Apoptosis Through Regulation of Cyclin D1 and Bad Expression

Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.

TCF7L2 Regulates Pancreatic Β-Cell Function Through PI3K/AKT Signal Pathway

Insulin/PI3K Signalling Pathway Regulates the Expression of Survivin in Liver Cancer HepG2 Cells

Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7–H4 expression through the MEK/ERK signaling pathway

Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: implications for the role of Zbtb7 in cell cycle regulation.